Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia

ClinicalTrials.gov ID: NCT02892422

Public ClinicalTrials.gov record NCT02892422. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 7:25 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Interventional, Open-label, Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety and tolerability of the long-term treatment with Lu AF35700.

Study identification

NCT ID
NCT02892422
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
H. Lundbeck A/S
Industry
Enrollment
528 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2016
Primary completion
Oct 9, 2019
Completion
Oct 9, 2019
Last update posted
Oct 25, 2020

2016 – 2019

United States locations

U.S. sites
32
U.S. states
12
U.S. cities
29
Facility City State ZIP Site status
US1018 Bellflower California
US1062 Costa Mesa California 92626
US1463 Culver City California
US1399 Escondido California 91945
US1104 Garden Grove California 92845
US1114 National City California 91950
US1459 Oceanside California
US1368 Orange California 92868
US1391 San Bernardino California 92408-3332
US1392 Torrance California 90502-4432
US1318 Lauderhill Florida 33319
US1130 Miami Florida 33122
US1129 North Miami Florida 33161-5834
US1402 Oakland Park Florida 33334-4400
US1403 Atlanta Georgia 30328
US1009 Atlanta Georgia 30331
US1046 Chicago Illinois 60640
US1423 Hoffman Estates Illinois 60169-1067
US1398 Shreveport Louisiana 71101-4603
US1404 Shreveport Louisiana 71104-2136
US1086 Flowood Mississippi 39232
US1444 Las Vegas Nevada 89102-1943
US1426 Berlin New Jersey 08009
US1244 Fresh Meadows New York 11432
US1394 New York New York 10032
US1416 New York New York 10035-6000
US1171 Rochester New York 14618
US1190 Staten Island New York 10312-6501
US1390 Charlotte North Carolina 28204-3110
US1124 Norristown Pennsylvania 19403
US1451 Austin Texas 78754-5122
US1065 Dallas Texas 75243

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 70 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02892422, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 25, 2020 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02892422 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →